These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9044850

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB, Thomas LN, Douglas RC, Vessey JP, Rittmaster RS.
    Prostate; 2004 Feb 01; 58(2):130-44. PubMed ID: 14716738
    [Abstract] [Full Text] [Related]

  • 3. Autocrine regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline.
    Hsieh JT, Wu HC, Gleave ME, von Eschenbach AC, Chung LW.
    Cancer Res; 1993 Jun 15; 53(12):2852-7. PubMed ID: 7684949
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The atypical GATA protein TRPS1 represses androgen-induced prostate-specific antigen expression in LNCaP prostate cancer cells.
    van den Bemd GJ, Jhamai M, Brinkmann AO, Chang GT.
    Biochem Biophys Res Commun; 2003 Dec 19; 312(3):578-84. PubMed ID: 14680804
    [Abstract] [Full Text] [Related]

  • 6. Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells.
    Fujii Y, Kawakami S, Okada Y, Kageyama Y, Kihara K.
    Am J Physiol Endocrinol Metab; 2004 Jun 19; 286(6):E927-31. PubMed ID: 14761877
    [Abstract] [Full Text] [Related]

  • 7. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
    Sadar MD, Gleave ME.
    Cancer Res; 2000 Oct 15; 60(20):5825-31. PubMed ID: 11059779
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells.
    Thelen P, Wuttke W, Jarry H, Grzmil M, Ringert RH.
    J Urol; 2004 May 15; 171(5):1934-8. PubMed ID: 15076315
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus.
    Jia L, Coetzee GA.
    Cancer Res; 2005 Sep 01; 65(17):8003-8. PubMed ID: 16140973
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells.
    Ren F, Zhang S, Mitchell SH, Butler R, Young CY.
    Oncogene; 2000 Apr 06; 19(15):1924-32. PubMed ID: 10773882
    [Abstract] [Full Text] [Related]

  • 13. Silibinin down-regulates prostate epithelium-derived Ets transcription factor in LNCaP prostate cancer cells.
    Thelen P, Jarry H, Ringert RH, Wuttke W.
    Planta Med; 2004 May 06; 70(5):397-400. PubMed ID: 15124082
    [Abstract] [Full Text] [Related]

  • 14. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP, Searle PF, Mautner V, James ND.
    Cancer Res; 2000 Jan 15; 60(2):334-41. PubMed ID: 10667585
    [Abstract] [Full Text] [Related]

  • 15. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen.
    Pang S, Dannull J, Kaboo R, Xie Y, Tso CL, Michel K, deKernion JB, Belldegrun AS.
    Cancer Res; 1997 Feb 01; 57(3):495-9. PubMed ID: 9012480
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells.
    Cronauer MV, Nessler-Menardi C, Klocker H, Maly K, Hobisch A, Bartsch G, Culig Z.
    Br J Cancer; 2000 Jan 01; 82(1):39-45. PubMed ID: 10638964
    [Abstract] [Full Text] [Related]

  • 18. Prostate specific antigen gene expression in androgen insensitive prostate carcinoma subculture cell line.
    Tsui KH, Feng TH, Chung LC, Chao CH, Chang PL, Juang HH.
    Anticancer Res; 2008 Jan 01; 28(4A):1969-76. PubMed ID: 18649734
    [Abstract] [Full Text] [Related]

  • 19. Exisulind and related compounds inhibit expression and function of the androgen receptor in human prostate cancer cells.
    Lim JT, Piazza GA, Pamukcu R, Thompson WJ, Weinstein IB.
    Clin Cancer Res; 2003 Oct 15; 9(13):4972-82. PubMed ID: 14581372
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor.
    Eder IE, Hoffmann J, Rogatsch H, Schäfer G, Zopf D, Bartsch G, Klocker H.
    Cancer Gene Ther; 2002 Feb 15; 9(2):117-25. PubMed ID: 11857028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.